IBM and Nvidia move quantum processors into supercomputing workflows
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
Quantum / NEWS BRIEF
Potential federal financing would expand PsiQuantum's California manufacturing and prototype-validation hub, but funding remains conditional and is not guaranteed.
PsiQuantum says it has received a conditional commitment for a loan of up to $150 million from the U.S. Department of War's Office of Strategic Capital. The proposed financing would support the company's 140,000-square-foot PsiFactory hub in Milpitas, California, where it plans to scale manufacturing and develop and validate prototype systems for its photonic, fault-tolerant quantum-computing architecture.
The company identifies test equipment for components and system assemblies, infrastructure for system integration and testing, and advanced cryogenic systems among the planned uses. PsiQuantum says the federal loan would be combined with its own co-investment. It did not disclose the amount of that co-investment or a schedule for completing the financing in the announcement.
This is a significant potential expansion of domestic quantum-manufacturing capacity, but it is not a completed loan or proof that PsiQuantum has built a useful fault-tolerant computer. The company explicitly says a final commitment depends on satisfying financial, legal, technical and regulatory conditions and is not guaranteed. Progress should be assessed through financial close, delivered equipment and independently verifiable prototype results; the announcement does not justify changing a quantum benchmark score.
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
OpenAI has released healthcare-focused computer-use capabilities across its API and clinical products, with configurable approvals, audit logs and new performance results that remain provider-reported.